Egg-Freezing showdown: which trigger yields more eggs for cancer patients?
NCT ID NCT07546136
First seen Apr 24, 2026 · Last updated May 25, 2026 · Updated 4 times
Summary
This study looks at two ways to trigger ovulation in women with cancer who are freezing their eggs before starting cancer treatment. About 200 women will receive either one drug (GnRH-a) or a combination of two drugs (GnRH-a plus hCG) to see which method retrieves more eggs and causes fewer side effects. The goal is to improve fertility preservation outcomes while reducing the risk of ovarian hyperstimulation syndrome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FERTILITY PRESERVATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITINGBologna, Bologna, 40138, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.